GlassScriptPhysician profile
William A Morton
NPI 1881614584
$5,105.90
in general payments reported to CMS, 2019-2025
42 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,302 · 2020: $841 · 2021: $952 · 2022: $406 · 2023: $644 · 2024: $676 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $907.28 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astellas Pharma US INC | $601.89 | 2019-2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $361.73 | 2019-2025 | Farxiga, Airsupra, Lokelma |
| Glaxosmithkline, LLC. | $308.49 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $289.72 | 2019-2021 | |
| Abbvie INC. | $288.43 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $188.33 | 2019-2024 | Xifaxan, Trulance |
| Amgen INC. | $181.31 | 2019-2024 | Repatha, Otezla |
| Boston Scientific Corporation | $180.33 | 2020-2025 | General - Pain Management |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.25 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Merck Sharp & Dohme LLC | $155.62 | 2019-2025 | Belsomra, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $152.93 | 2024 | |
| Sunovion Pharmaceuticals INC. | $126.13 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $120.53 | 2019-2024 | Eliquis, Camzyos |
| Lilly USA, LLC | $112.64 | 2021-2024 | Mounjaro |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.